Safety and feasability of Predictive Intelligent Control of Oxygenation (PRICO) on the Neonatal Intensive Care Unit (NICU)

Completed

• Conditions: hyaline membrane disease; respiratory distress syndrome of the newborn; under developed lungs; 10028971

• Registration Number: NL-OMON47374
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 72

Inclusion Criteria

Neonates who require respiratory support and supplemental oxygen therapy

Exclusion Criteria

Planned dismissal or transfer to a other hospital within 24 hours

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main parameter during the study is the time the SpO2 spend within the<br /><br>target range.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are the number of hyper and hypoxic events, average maximum<br /><br>and minimum SpO2 during these events, number of FiO2 adjustments (manual and<br /><br>automated) and cerebral oxygen saturation.</p><br>